Should SA’s public hospitals go solar?

Posted in: Healthcare system, Latest

For businesses and households that can afford it, solar panels and batteries offer a way to keep the lights on during South Africa’s ongoing bouts of loadshedding. Such technologies may also offer a solution for healthcare facilities, where a reliable energy supply can be a matter of life and death. Nthusang Lefafa spoke to stakeholders and experts in the public and private health sectors about the promise of solar energy to mitigate the impact of loadshedding on health services.

As with COVID-19, the effects of TB can linger long after it is cured

Posted in: Healthcare system, Latest, TB, TB

According to the World Health Organization, of the roughly 10 million people who fall ill with TB annually, over 80% survive, in most cases due to a six-month treatment course. Unfortunately, as with long COVID, being cured is not always the last hurdle and many people go on to struggle with post-TB lung disease. Tiyese Jeranji asked local experts about this sometimes-neglected area of TB care.

As with COVID-19, the effects of TB can linger long after it is cured

Testing stool can help detect TB in kids

Posted in: Edition 14: Tuberculosis, Edition 7: TB, Latest, TB, TB

Diagnosing tuberculosis is difficult in people who struggle to cough up sputum samples – a particular problem in children and people living with HIV. One promising alternative to testing sputum is to test stool. Tiyese Jeranji unpacks the latest developments in this area.

Testing stool can help detect TB in kids

In-depth: New resistance tests set to improve TB treatment

Posted in: Edition 10: Drug-resistant TB, Edition 14: Tuberculosis, Latest, TB, TB

Tuberculosis (TB) can be resistant to treatment with several different drugs. Tests that identify which drugs someone’s TB is resistant to are critical to ensuring that people are not treated with drugs that don’t work for them, especially given the significant side effects associated with some of the drugs. Elri Voigt assesses the state of play in testing for TB drug resistance and the promise of exciting new technologies, such as whole genome sequencing.

In-depth: New resistance tests set to improve TB treatment

56 000 TB deaths in SA in 2021, estimates WHO

Posted in: Healthcare system, Latest, TB, TB

In 2021, an estimated 304 000 people in South Africa fell ill with tuberculosis and 56 000 died from the disease, according to new World Health Organization (WHO) figures released on Thursday. Elri Voigt unpacks the latest findings and asks local experts for their responses.

56 000 TB deaths in SA in 2021, estimates WHO

In-depth: The complex relationship between TB and mental health

Posted in: Healthcare system, Latest, Mental Health, TB, TB

Tuberculosis (TB) disease and all the disruption and stress that goes along with it can take a toll on someone’s mental health, and mental health problems can in turn make someone more vulnerable to TB. In the wake of World Mental Health Day 2022, Tiyese Jeranji explores the complex links between mental health and TB.

In-depth: The complex relationship between TB and mental health

Smart pill box can help with TB treatment, but it’s not for everyone

Posted in: Spotlight

Tuberculosis (TB) can be cured, but completing TB treatment can sometimes be difficult. Treatment takes a minimum of six months and some of the medicines have side effects – especially those used to treat drug-resistant forms of TB. Tiyese Jeranji asks what role smart pill boxes could play in helping people complete TB treatment.

Smart pill box can help with TB treatment, but it’s not for everyone

COVID-19: Benefits of vaccines still far outweigh risks, experts say

Posted in: COVID-19, Latest

The benefits of approved COVID-19 vaccines still far outweigh the risks, experts say following a recently reported death in South Africa linked to Johnson & Johnson’s COVID-19 vaccine. Adele Baleta reports.

COVID-19: Benefits of vaccines still far outweigh risks, experts say

Analysis: Vaccine partnership with US government boosts prospects for local production

Posted in: COVID-19, Latest

Earlier this month Cape Town-based vaccine company Afrigen announced a formal collaboration with the United States National Institute of Allergy and Infectious Diseases’ (NIAID’s) Vaccine Research Centre. Catherine Tomlinson unpacks what this deal may mean for local production of vaccines for COVID-19 and other diseases.

Analysis: Vaccine partnership with US government boosts prospects for local production

Shorter, simpler DR-TB regimen expected later this year

Posted in: Edition 10: Drug-resistant TB, Latest, NSP and SANAC, TB, TB

A new six-month treatment regimen for drug-resistant forms of tuberculosis is expected to be rolled out in the public sector later this year – current regimens take anything from nine to 18 months. Catherine Tomlinson unpacks why the switch is important and outlines what still needs to happen to make it a reality.

Shorter, simpler DR-TB regimen expected later this year

Opinion: Reframing the right to healthcare in terms of insurance cover is a bad idea

Posted in: Healthcare system, Latest, NHI, Spotlight on NHI

Framing the fundamental human right to healthcare as insurance cover opens it up for exploitation. It blocks any possibility of achieving equity in health care. Here Dr Louis Reynolds from the People’s Health Movement of South Africa explains why and how.

Opinion: Reframing the right to healthcare in terms of insurance cover is a bad idea

In-depth: SA company gearing up to make API

Posted in: Access to Medicines, Healthcare system, Latest, Science

While various medicines are produced in South Africa, the active pharmaceutical ingredients going into these medicines are mostly still imported. Catherine Tomlinson reports on a local company that is trying to change that – starting with active pharmaceutical ingredients for tuberculosis and COVID-19 medicines.